This inventor holds 2 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: Oxford Biomedica (UK) Limited. Active years: 2008-2009.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2008-2009
Title: Yasuhiro Ikeda: Innovator in Retroviral Vector Technology
Introduction
Yasuhiro Ikeda is a notable inventor based in London, GB. He has made significant contributions to the field of biotechnology, particularly in the development of retroviral vectors. With a total of 2 patents, his work has implications for gene therapy and cellular biology.
Latest Patents
Ikeda's latest patents focus on retroviral vectors. The first patent describes a retroviral vector that comprises and is capable of expressing a nucleotide of interest (NOI). This NOI encodes an RNA or protein that is harmful to a cell. The second patent reiterates this innovative approach, emphasizing the potential applications in therapeutic settings.
Career Highlights
Throughout his career, Yasuhiro Ikeda has worked with prominent companies in the biotechnology sector. Notably, he has been associated with Oxford Biomedica Limited and Oxford Biomedica, Inc. His work in these organizations has allowed him to advance his research and contribute to the development of cutting-edge technologies.
Collaborations
Ikeda has collaborated with several professionals in his field, including Kyriacos Andreou Mitrophanous and Mary Collins. These collaborations have enriched his research and expanded the impact of his inventions.
Conclusion
Yasuhiro Ikeda's contributions to retroviral vector technology highlight his innovative spirit and dedication to advancing biotechnology. His patents and career achievements reflect his significant role in the scientific community.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile